AGBL4 and papillary renal cell carcinoma: In humans, CCP6 has been linked to cancer progression; patients with renal adenocarcinoma frequently display decreased CCP6 levels, leading to the accumulation of the polyglutamylated DNAJC7 and dysregulation of HSP70 and HSP90 proteins [7].